1. The Role of Induction Therapy for Resectable Non-Small Cell Lung Cancer

   • Thomas E. Stinchcombe
   • Mark A. Socinski

   Leading Article 18 September 2012 Pages: 321 - 332

   

2. Monoclonal Antibodies in the Treatment of Non-Hodgkin’s Lymphoma

   • Michelle A. Fanale
   • Anas Younes

   Review Article 18 September 2012 Pages: 333 - 350

   

3. The Epidemiology, Pathogenesis and Treatment of Pseudomonas aeruginosa Infections

   • James A. Driscoll
   • Steven L. Brody
   • Marin H. Kollef

   Review Article 18 September 2012 Pages: 351 - 368

   

4. Use of Sirolimus in Solid Organ Transplantation

   • Joshua J. Augustine
   • Kenneth A. Bodziak
   • Donald E. Hricik

   Review Article 18 September 2012 Pages: 369 - 391

   

5. Antianginal Efficacy and Safety of Ivabradine Compared with Amlodipine in Patients with Stable Effort Angina Pectoris

   • Witold Ruzyllo
   • Michal Tendera
   • Kim M. Fox

   Original Research Article 18 September 2012 Pages: 393 - 405

   

6. Insulin Lispro

   • Dene Simpson
   • Paul L. McCormack
   • Katherine A. Lyseng-Williamson

   Adis Drug Evaluation 18 September 2012 Pages: 407 - 434

   

7. Agalsidase Beta

   • Gillian M. Keating
   • Dene Simpson

   Adis Drug Evaluation 18 September 2012 Pages: 435 - 456

   

8. Rupatadine

   • Susan J. Keam
   • Greg L. Plosker

   Adis Drug Evaluation 18 September 2012 Pages: 457 - 474

   

9. Sorafenib

   • Kate McKeage
   • Antona J. Wagstaff

   Adis Drug Evaluation 18 September 2012 Pages: 475 - 483

   

10. Sorafenib in Advanced Renal Cancer

    • Michael Staehler

    Adis Drug Evaluation 18 September 2012 Pages: 484 - 484

11. Sorafenib in Advanced Renal Cancer

    • Brian I. Rini

    Adis Drug Evaluation 18 September 2012 Pages: 484 - 485